Invivyd, Inc. (IVVD)
NASDAQ: IVVD · Real-Time Price · USD
0.5817
-0.0203 (-3.37%)
At close: Oct 30, 2026, 4:00 PM EDT
0.6047
+0.0230 (3.95%)
After-hours: Oct 30, 2026, 7:58 PM EDT
Invivyd Market Cap
Invivyd has a market cap or net worth of $171.46 million as of October 30, 2026. It is the 21,519th most valuable company in the world and the 3,690th biggest in the United States. Its market cap has decreased by 58.35% in one year.
Market Cap
171.46M
Enterprise Value
19.77M
1-Year Change
-58.35%
Global Rank
Country Rank
#3,690 United States
Category
ChartMarket Cap Chart
Since August 6, 2021, Invivyd's market cap has decreased from $2.27B to $171.46M, a decrease of -92.43%. That is a compound annual growth rate of -38.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 171.46M | -74.95% |
| Dec 31, 2025 | 684.49M | 1,191.45% |
| Dec 31, 2024 | 53.00M | -87.78% |
| Dec 29, 2023 | 433.85M | 165.40% |
| Dec 30, 2022 | 163.47M | -79.76% |
| Dec 31, 2021 | 807.69M | -64.36% |
| Aug 6, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zentalis Pharmaceuticals | 179.88M |
| Sionna Therapeutics | 174.52M |
| MediWound | 174.29M |
| ALX Oncology Holdings | 171.46M |
| Oramed Pharmaceuticals | 170.91M |
| AN2 Therapeutics | 169.44M |
| Adagene | 167.19M |
| Veraxa Biotech AG | 164.03M |